INNO fundamentals
An in-depth look to INNOCAN PHARMA CORPORATION operating, investing, and financing activities
INNO free cash flow for Q4 23 is -1.79 M CAD. For 2023, INNO free cash flow was -5.33 M CAD and operating cash flow was -5.27 M CAD.
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CAD
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM